With changing industry trends and new legislation, having robust real-world evidence (RWE) for your organization is more important than ever.

In this on-demand webinar, you'll hear from experts as they discuss regulatory submissions and how to select quality data. You'll gain insights into PINC AI^™ Applied Sciences RWE and how its quality data, which represents over one billion individual patient encounters, can be fit-for-purpose* for your regulatory use.

Topics of discussion will also include:

• Information about recent RWE legislation, including FDA guidance
• Industry trends and resources for filing regulatory submissions
• Case studies from submitting RWE for regulatory submissions, including learnings and challenges
• Leveraging RWE in clinical trials

SPEAKERS:

	Myla Maloney Chief Growth Officer, Premier, Inc., PINC AI™ Applied Sciences
	Soumi Saha Senior Vice President of Government Affairs, Premier, Inc.